Oaktree Acquisition Corp.... (OACCU)
NASDAQ: OACCU
· Real-Time Price · USD
10.65
0.05 (0.47%)
At close: May 23, 2025, 3:59 PM
10.65
0.00%
After-hours: May 23, 2025, 04:00 PM EDT
Company Description
Oaktree Acquisition Corp.
III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
The company was founded in 1995 and is headquartered in Los Angeles, CA.
Oaktree Acquisition Corp. III Life Sciences Unit
| Country | United States |
| IPO Date | Oct 24, 2024 |
| Industry | Asset Management |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Zaid Pardesi |
Contact Details
Address: No Address available Los Angeles, United States | |
| Website | https://www.oaktreeacquisitioncorp.com/oac-iii |
Stock Details
| Ticker Symbol | OACCU |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0002029769 |
| CUSIP Number | n/a |
| ISIN Number | KYG6717R1204 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Zaid Pardesi | Chief Executive Officer & Director |
| Courtney Conigliaro | Chief Financial Officer |
| Mathew M. Pendo | Chief Operation Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 14, 2025 | 10-Q | Quarterly Report |
| May 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| May 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| May 13, 2025 | SCHEDULE 13G | Filing |
| May 09, 2025 | SCHEDULE 13G | Filing |
| Mar 27, 2025 | 10-K | Annual Report |
| Oct 21, 2024 | CORRESP | Filing |
| Oct 21, 2024 | CORRESP | Filing |
| Oct 18, 2024 | CORRESP | Filing |
| Oct 18, 2024 | UPLOAD | Filing |